Hosted on MSN1mon
Sanofi gets FDA approval for NovoLog insulin biosimilarrapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children with diabetes mellitus. The FDA approved 3 mL single-patient-use prefilled pen and 10 mL ...
NovoLog is also available in pen injector formats. Before Merilog, the FDA has given the go-ahead to two biosimilars of Sanofi's basal insulin product Lantus (insulin glargine) – Viatris ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback